|
|
Article: Cancer vaccine market may reach $6B by 2010, says R&M.(Research and Markets)(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- June 13, 2005
CopyrightCOPYRIGHT 2005 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Dublin, Ireland-based Research and Markets says that its new report, Cancer Vaccines: Measuring Market Potential, is now available, providing an overview of the emerging market for cancer vaccines and assessment of their potential impact on a number of markets.
At present, there are more than 20 Phase III clinical trials underway for various indications and new approvals may come as early as 2005, the report notes. According to R&M, the value of the cancer vaccines market could hit $6.0 billion by 2010.
The group says that the report offers information, insight and analysis key to understanding the impact of cancer vaccines on the sector, by: - gauging ...